Fresenius Medical Care Management
Management Kriterienprüfungen 1/4
Fresenius Medical Care's CEO ist Helen Giza , ernannt in Nov 2019, hat eine Amtszeit von 4.58 Jahren. Die jährliche Gesamtvergütung beträgt €5.53M , bestehend aus 30.1% Gehalt und 69.9% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.005% der Aktien des Unternehmens, im Wert von €503.54K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.5 Jahre bzw. 0.5 Jahre.
Wichtige Informationen
Helen Giza
Geschäftsführender
€5.5m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 30.1% |
| Amtszeit als Geschäftsführer | 4.6yrs |
| Eigentum des Geschäftsführers | 0.005% |
| Durchschnittliche Amtszeit des Managements | 1.5yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | less than a year |
Jüngste Management Updates
Recent updates
These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively
Jun 17
What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E
May 30Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year
May 10Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19
Apr 26Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 29Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19
Mar 14Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19
Feb 23When Should You Buy Fresenius Medical Care AG (ETR:FME)?
Feb 22Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings
Feb 03Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital
Jan 16Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?
Dec 29Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Nov 21Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal
Oct 16Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?
Sep 28Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Aug 21An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued
Jul 23Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture
Jul 09These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively
Jun 25What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?
May 07Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?
Apr 23We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt
Mar 24Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?
Feb 03Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?
Jan 19Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively
Jan 04Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt
Dec 17Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think
Nov 08Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | €484m |
| Dec 31 2023 | €6m | €2m | €499m |
| Sep 30 2023 | n/a | n/a | €450m |
| Jun 30 2023 | n/a | n/a | €596m |
| Mar 31 2023 | n/a | n/a | €602m |
| Dec 31 2022 | €3m | €1m | €673m |
| Sep 30 2022 | n/a | n/a | €763m |
| Jun 30 2022 | n/a | n/a | €806m |
| Mar 31 2022 | n/a | n/a | €878m |
| Dec 31 2021 | €2m | €855k | €969m |
| Sep 30 2021 | n/a | n/a | €918m |
| Jun 30 2021 | n/a | n/a | €998m |
| Mar 31 2021 | n/a | n/a | €1b |
| Dec 31 2020 | €2m | €855k | €1b |
| Sep 30 2020 | n/a | n/a | €1b |
| Jun 30 2020 | n/a | n/a | €1b |
| Mar 31 2020 | n/a | n/a | €1b |
| Dec 31 2019 | €2m | €108k | €1b |
Vergütung im Vergleich zum Markt: HelenDie Gesamtvergütung ($USD5.94M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt German ($USD5.00M).
Entschädigung vs. Einkommen: HelenDie Bezüge der Mitarbeiter sind um mehr als 20 % gestiegen, während die Unternehmensgewinne im vergangenen Jahr um mehr als 20 % gesunken sind.
Geschäftsführer
Helen Giza (56 yo)
4.6yrs
Amtszeit
€5,528,000
Vergütung
Ms. Helen Giza is Chief Executive Officer and Chair of the Management Board of Fresenius Medical Care Management AG, General Partner of Fresenius Medical Care AG & Co. KGAA from December 6, 2022. She serve...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Chair of Management Board & CEO | 4.6yrs | €5.53m | 0.0047% € 485.6k | |
| CFO & Member of the Management Board | less than a year | €887.00k | keine Daten | |
| Global Chief Medical Officer & Member of Management Board | 4.4yrs | €3.13m | 0.0062% € 641.2k | |
| CEO of Care Enablement & Member of Management Board | 2.4yrs | €3.71m | 0.0039% € 401.5k | |
| CEO of Care Delivery & Member of Management Board | less than a year | keine Daten | keine Daten | |
| Executive VP and Head of Investor Relations | no data | keine Daten | keine Daten | |
| Global Head of Legal | no data | keine Daten | keine Daten | |
| Senior Vice President of Corporate Communications & Governmental Affairs | no data | keine Daten | keine Daten | |
| Senior Vice President of Research & Development | no data | keine Daten | keine Daten | |
| Senior Vice President of Manufacturing and Supply Chain Operations | no data | keine Daten | keine Daten | |
| Senior Vice President - Quality Management International | no data | keine Daten | keine Daten | |
| Executive Vice President of Western Europe & Nephrocare Coordination EMEALA | no data | keine Daten | keine Daten |
1.5yrs
Durchschnittliche Betriebszugehörigkeit
56.5yo
Durchschnittliches Alter
Erfahrenes Management: FMEDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.5 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Independent Member of Supervisory Board | less than a year | €20.00k | keine Daten | |
| Chairman of the Supervisory Board | less than a year | €444.00k | keine Daten | |
| Independent Member of Supervisory Board | 8.1yrs | €230.00k | keine Daten | |
| Independent Member of Supervisory Board | less than a year | €21.00k | keine Daten | |
| Independent Member of Supervisory Board | 3.1yrs | €151.00k | keine Daten | |
| Employee Representative Deputy Chairwoman of the Supervisory Board | less than a year | keine Daten | keine Daten | |
| Member of Supervisory Board | less than a year | €158.00k | keine Daten | |
| Employee Representative Member of Supervisory Board | less than a year | keine Daten | keine Daten | |
| Employee Representative Member of the Supervisory Board | less than a year | keine Daten | keine Daten | |
| Employee Representative Member of the Supervisory Board | less than a year | keine Daten | keine Daten | |
| Employee representatives Member of the Supervisory Board | less than a year | keine Daten | keine Daten | |
| Employee representatives Member of the Supervisory Board | less than a year | keine Daten | keine Daten |
0.5yrs
Durchschnittliche Betriebszugehörigkeit
56yo
Durchschnittliches Alter
Erfahrener Vorstand: FMEDie Vorstandsmitglieder gelten nicht als erfahren ( 0.4 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.